A University of Tokyo clinical investigation team will commence the nation’s first clinical trial centering on a vaccine for the Ebola virus. Professor Yoshihiro Kawaoka and colleagues from the Institute of Medical Science at the prestigious Japanese institution,...
South Korean biopharma companies, such as Chong Kun Dang and Dong-A ST, move to launch biosimilars in Japan despite some trade tensions, as their therapies will be managed and distributed by Japanese firms. For example, both firms have applied for their respective...
Tokyo, Japan-based M3 Inc. is a network of physicians worldwide. With 250,000 members in Japan and 3.5 million worldwide in the USA, UK, China, Korea and India, they provide a treasure trove for research access (investigators),health information and career...
Iqra Farooq with AML Global Portal writes the prognosis of younger patients with acute myeloid leukemia (AML) has improved with the development of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and advanced supportive care. But, in most elderly...
A bio-venture company has confirmed improved arm and leg function in clinical trials of patients who underwent stem cell shots to repair damaged brain tissue. Tokyo-based SanBio Inc. announced the findings at the meeting of American Association of Neurological...
Jeong Sae-Im writing for Korea Biomedical Review reports that a recent conference in Korea, BIO KOREA 2019 at COEX, brought together prominent speakers from a variety of Korean research institutions. Some observations from the conference: Korea may be pulling ahead of...
